Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases?

By R. Adam, G. Pascal, D. Castaing, D. Azoulay, V. Delvart, B. Paule, Francis Levi, H. Bismuth. Annals of Surgery, 2004

1,031 citations recorded by the source corpus.

Subfields: Hepatology, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/046e7b3ee7303577a8a1bd92e809cef318279f1e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. L. Ellis

Citations in the corpus

• Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. (2005, background): “This group also showed that even patients with primarily resectable metastases who do not respond to systemic chemotherapy do not benefit from resection [54].”
• Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. (2008, background): “tumors, chemotherapy can identify nonresponders who may not benefit from resection.(7)”